11:32 AM EST - Immunovaccine Inc. : Announced the publication of a pre-clinical study using magnetic resource imaging to follow cancer peptide uptake in tumor models, and to correlate this immune activation to the resulting anti-cancer T cell activity. The Journal of Biomedical Science study, titled “Unique Depot Formed by an Oil Based Vaccine Facilitates Active Antigen Uptake and Provides Effective Tumour Control,” compared the mechanism of action (MOA) of Immunovaccine’s platform for immunotherapeutic stimulation with other technologies. Immunovaccine Inc.
shares T.IMV are trading up $0.08 at $2.08.
